Betahistine is used to treat Vertigo, tinnitus and hearing loss associated with Ménière's syndrome.

BETAHISTINE 16MG TABLET,84CT

ACCORD

₦5,650.00

(No reviews yet) Write a Review

SKU:: BET272B
UPC:

Current Stock:

Quantity:

Adding to cart… The item has been added

Description

Betahistine is used to treat Vertigo, tinnitus and hearing loss associated with Ménière's syndrome.

Related Products

Premarin is an estrogen only HRT.

Premarin 0.3-1.25mg daily is the usual starting dose for women without a uterus. Continuous administration is recommended.

Treatment of Postmenopausal Symptoms

For initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see section 4.4) should be used.

Treatment to control menopausal symptoms should be initiated with Premarin 0.3mg. If symptoms are not adequately controlled, higher doses of Premarin may be prescribed. Once treatment is established the lowest effective dose necessary for the relief of symptoms should be used. Patients should be re-evaluated periodically to determine if treatment for symptoms is still necessary.

AVAILABLE IN NIGERIA

PREMARIN 0.625MG TABLETS,84CT

₦115,000.00

PREMARIN 1.25MG TABLET,84CT

PREMARIN 1.25MG TABLET,84CT

₦110,000.00

Metformin belongs to a group of medicines called oral hypoglycaemics.
It works by reducing the level of sugar in the blood.
Metformin Tablets are used for the treatment of Type 2 diabetes in patients when diet and exercise have not been enough to keep their blood sugar level under control, especially when these patients are overweight.

METFORMIN 500MG TABLETS,84CT

₦3,800.00

PROGYNOVA 2MG TABLETS,84CT — Add to Cart The item has been added

PROGYNOVA 2MG TABLETS,84CT

₦37,000.00

Candesartan Cilexetil is indicated for the:

• Treatment of primary hypertension in adults.

• Treatment of hypertension in children and adolescents aged 6 to <18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when Angiotensin Converting Enzyme (ACE)-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated — Add to Cart The item has been added

CANDESARTAN 16MG TABLETS,28CT

₦4,500.00